STERIS plc (STE) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.

Total Assets Chart for STERIS plc

STERIS plc (STE) total assets for FY2026 were USD 10.7B, a 5.8% change from FY2025. STERIS plc's total assets grew from USD 4.4M in 1991 to USD 10.7B in 2026 (243927.3% over 35 years). Total assets compound annual growth rate: 5-year CAGR of 10.3%, 10-year CAGR of 7.2%, 20-year CAGR of 11.6%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$22.59B
Implied Share Price
$231.78
Enterprise Value
$24.34B
Revenue (TTM)
$5.94B
EBITDA
$1.60B
Profit Margin
13.18%
Trailing P/E
29.19
Forward P/E
20.92
Price/Book (MRQ)
3.16
Price/Sales (TTM)
3.81
EV/EBITDA
15.27
EV/Revenue
4.10
Dividend Yield
1.06%
Book Value
$73.45
Free Cash Flow (FY2026)
$972.40M
Free Cash Flow Yield
4.30%

Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.